BOPA Report on Aseptic Capacity – Survey Re-opened

The results of the BOPA/Royal Marsden IV SACT survey were presented to the NHS Infusions and Special Medicines Board earlier in the month and generated a great deal of interest.  NHS England  are keen to help but would like to collect more data to properly inform their next steps.  Following the ‘Aseptics, Transform!’ session at the BOPA conference we have decided to reopen the survey to collect more responses. If your Trust has already completed the survey then you do not need to do it again.  The survey itself doesn’t take long to complete if you have the required information at your fingertips.  To make things easier we have created a pdf version of the survey so you can collect it all together in advance.

Please see the letter for more information IV SACT Survey – Letter to Support re-opened survey – BOPA

The link, below, will be re-opened for submissions until Wednesday 9th November

https://www.surveymonkey.co.uk/r/K5NJRBV

The pdf version of the survey is available here: BOPA IV SACT Survey – July 2022 – BOPA

Thank you

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article